Merck climbs after Keytruda cancer drug succeeds in key trial via @FT
https://t.co/uj8SpHUeic— The Propell Group (@ThePropellGroup) January 17, 2018
Merck climbs after Keytruda cancer drug succeeds in key trial via @FT
https://t.co/uj8SpHUeic— The Propell Group (@ThePropellGroup) January 17, 2018